Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Catherine Ju-Ying Wu

(PQD1) lmpact of cytotoxic and targeted therapy on clonal evolution of CLL

Leukaemia

Christopher S Carlson

Impact of primary tumor development stage on prognosis and outcome in B-ALL

Leukaemia

Pediatric oncology or childhood cancer

E. Blair Holladay

Partners for Cancer Diagnostic and Treatment in Africa

Breast

Pathology

Oliver W. Press

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Alejandro Gutierrez

Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL

Leukaemia

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Martha Lassiter

2012 Tata Memorial Hospital Bone Marrow Transplant Program in Kolkata, India

Hodgkin lymphoma

Hematology and hematologic malignancies

Helen E. Heslop

Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT

Leukaemia

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Leukaemia Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology